Product Images Octaplas
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 2 images provide visual information about the product associated with Octaplas NDC 68982-955 by Octapharma Usa Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image File - img0001
This seems to be a table that shows the results of a virus reduction factor test on production. The test was completed in one step (Step I). S/D (unknown acronym) treatment resulted in a virus reduction factor of greater than 6.18, or a value of >503 [log10], or an approximate value of 512. Global reduction factor was also greater than 6.18, with a value of 2503 [log10], or an approximate value of 2512.*
Image File - img0002
This is a description of Ocraplas Pooled Plasma (Human), which has been treated with Solvent/Detergent to make it suitable for intravenous use. It is only available on prescription and each 200 mL contain 9-14 g human plasma proteins, 0.88-1.48 g sodium citrate dihydrate, 0.06-0.24 g sodium dihycrogen phosphate diydrate and 0.80-1.20 g alycine. The product is free from preservatives and should be stored at -18°C or below, protected from light. The product should be used immediately after thawing, should not be refrozen or used if cloudy or has any signs of deposit. The manufacturer's license number is 1646.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.